{
    "laboratory_examinations": [
        {
            "procedure_name": "HbA1c",
            "date": "Not specified",
            "findings": "8.8% (upper limit of the nondiabetic range, 6.1%)",
            "changes_over_time": "HbA1c fell to 7.3% 5 months after initiation of CSII and rose to 9.3% 1 yr after."
        },
        {
            "procedure_name": "C-peptide",
            "date": "Not specified",
            "findings": "0.18 nmol/liter (low)",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Microalbumin to creatinine ratio",
            "date": "Not specified",
            "findings": "32.9 mg/mmol (normal range 13.4 mg/mmol)",
            "changes_over_time": "Stable proteinuria was documented, predating her onset of DM by 8 yr."
        },
        {
            "procedure_name": "Creatinine kinase (CK)",
            "date": "Spring 2003",
            "findings": "Elevated",
            "changes_over_time": "Concurrent troponin was negative, ruling out cardiac ischemia and raising suspicion of skeletal muscle breakdown."
        },
        {
            "procedure_name": "Stress thallium test",
            "date": "1 yr after CoQ10 initiation",
            "findings": "Improvement in exercise tolerance from 7â€“12 min.",
            "changes_over_time": "Only fair exercise capacity initially; 7 min maximum before CoQ10 treatment."
        },
        {
            "procedure_name": "Audiometry testing",
            "date": "1 yr after CoQ10 initiation",
            "findings": "No change in the rate of hearing decline.",
            "changes_over_time": "Progressive hearing loss documented since age 37."
        }
    ]
}